T1	Disorder 8 32	Chromosome abnormalities
N1 	Reference T1 UMLS:C0008626	Chromosome abnormalities
T2	Pharmacological_substance 39 51	chlorambucil
N1000 	Reference T2 MeSH:D002699	chlorambucil
T3	Disorder 63 81	polycythaemia vera
N2 	Reference T3 UMLS:C0032463	polycythaemia vera
T4	Disorder 140 158	polycythaemia vera
N3 	Reference T4 UMLS:C0032463	polycythaemia vera
T5	Pharmacological_substance 240 252	chlorambucil
N1001 	Reference T5 MeSH:D002699	chlorambucil
T6	Disorder 370 394	chromosome abnormalities
N4 	Reference T6 UMLS:C0008626	chromosome abnormalities
T11	Pharmacological_substance 753 765	chlorambucil
N1002 	Reference T11 MeSH:D002699	chlorambucil
T13	Subject 124 134	2 patients
T14	Disorder 160 162	PV
N5 	Reference T14 UMLS:C0032463	PV
T8	Disorder 688 690	PV
N6 	Reference T8 UMLS:C0032463	PV
T18	Disorder 983 1005	polycythaemic disorder
T19	Coreferring_mention 254 267	Both patients
T20	Disorder 459 504	deletion of chromosome no. 12, del (12) (p11)
T21	Pharmacological_substance 432 448	myelosuppressive
T23	Disorder 625 654	deletion of chromosome no. 20
N7 	Reference T23 UMLS:C0008628	deletion of chromosome no. 20
T24	Disorder 784 825	balanced translocation, t (1;5) (p36;q31)
T15	Disorder 951 975	leukaemic transformation
T29	Subject 850 870	none of the patients
